Home › Trial NCT07207785
PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma
- Trial IDNCT07207785
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorFondazione Italiana Linfomi - ETS
- Enrollment56
- Start date2026-02-01
- ConditionsMantle Cell Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.